Dr Na Li
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
52 Scholarly works
4 Projects
HIGHLIGHTS
2025
Other
Table 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.307063352025
Other
Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.307063472025
Other
Figure 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.307063682025
Other
Supplementary Figures S1-S13 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.307063562024
Research grants (other domestic)
Poor Outcome Breast Cancer: Identifying Genetic Risk Factors and New Treatments
2024
Research grants (other domestic)
Novel Cellular Models to Investigate the Polygenic Risk of Breast Cancer
2021
Research Grant
Finding New Genes That Cause Familial High Grade Serious Ovarian Cancer
RECENT SCHOLARLY WORKS
2025
Other
Table 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.307063442025
Other
Supplementary Methods 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.307063532025
Other
Figure 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.307063712025
Other
Figure 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.307063622025
Other
Table 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.307063322025
Journal article
Efficacy prediction of neoadjuvant cadonilimab plus FLOT therapy for advanced gastric cancer: a study based on body composition changes
DOI: 10.3389/fonc.2025.1601819
RECENT PROJECTS
2020
Research Grant
Validation of Novel Breast Cancer Predisposition Genes Identified in the Halo Study; A Large-Scale Familial Breast Cancer Case-Control Dataset